Mallinckrodt Pharmaceuticals is recalling approximately 170,448 bottles of Amitiza (lubiprostone) capsules, used to treat chronic constipation, because some bottles contain the wrong dosage. Bottles labeled as 8 mcg were found to contain 24 mcg capsules, and bottles labeled as 24 mcg were found to contain 8 mcg capsules. This labeling mix-up occurred across 60-count trade bottles distributed nationwide. Because patients may inadvertently take three times the intended dose or receive an ineffective lower dose, consumers should immediately verify their medication and contact a healthcare provider.
Taking the wrong dosage of medication due to a labeling error can lead to either an overdose of the active ingredient, potentially causing increased side effects, or an underdose, which may fail to treat the underlying medical condition effectively.
Healthcare provider consultation and pharmacy refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.